FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly to drug preparation of deanol aceglumate. An injection drug formulation is proposed, containing ingredients as follows: deanol aceglumate, sugars (sorbitol, xylitol, and others), aminoacetic versene, optionally succinic acid, malic acid, and N-dimethylaminoethanol. It was demonstrated, that the injection drug formulation of deanol aceglumate shows neuroprotective action and can be applied to acute cerebral circulation injury, preventing from cerebral ischemia damage.
EFFECT: generation of stable and sterile injection drug formulation of deanol aceglumate, suitable for applying in diabetes cases.
3 cl, 4 ex, 2 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL INJURY AND HYPOXIA, REPRESENTING MAGNESIUM 2-AMINOETHANESULFONATE, PHARMACEUTICAL COMPOSITIONS | 2010 |
|
RU2453310C1 |
SOLID DOSAGE DRUG FORMULATION, INCREASING PHYSICAL AND MENTAL PERFORMANCE | 2006 |
|
RU2331413C1 |
DEANOL ACEGLUMATE DEMONSTRATING ANTIULCEROGENIC, GASTROPROTECTIVE AND ENTEROPROTECTIVE ACTIVITY, COMBINATION POSSESSING ANTIULCEROGENIC, GASTROPROTECTIVE AND ENTEROPROTECTIVE ACTIVITY (VERSIONS), PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2435575C2 |
METHOD OF TREATING ISCHEMIC STROKE | 2013 |
|
RU2554500C2 |
NEUROPROTECTIVE AGENT BASED ON BIS{2-[(2E)-4-HYDROXY-4-OXOBUT-2-ENOYLOXY]-N,N-DIETHYLETHANAMINE}BUTANDIOATE | 2015 |
|
RU2588365C1 |
AGENT FOR REDUCTION OF GLUTAMATE-INDUCED APOPTOSIS AND INHIBITION OF NMDA-RECEPTOR, POSSESSING IMMUNOMODULATORY ACTION, FOR TREATING NERVOUS SYSTEM DISORDERS, EFFECTS OF CRANIOCEREBERAL INJURY AND ISCHEMIC AND HEMORRHAGIC STROKE | 2013 |
|
RU2605339C2 |
MEDICINAL COMPOSITION | 2001 |
|
RU2213562C2 |
INJECTION DOSAGE FORM FOR TREATING ACUTE ISCHEMIC STROKE AND CRANIOCEREBERAL INJURY, METHOD FOR PREPARING AND USING | 2009 |
|
RU2431496C2 |
MAGNESIUM BIS (2-AMINOETHANESULFONIC ACID)-BUTANEDIOATE, WHICH HAS ANTIHYPOXIC, NEUROPROTECTIVE AND HYPOCOAGULANT ACTIVITY | 2017 |
|
RU2671982C1 |
INJECTION DOSAGE FORM FOR ACUTE STROKE TREATMENT, METHOD OF PRODUCTION AND APPLICATION THEREOF | 2005 |
|
RU2330680C2 |
Authors
Dates
2008-08-20—Published
2006-11-16—Filed